Cargando…
Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease
The monkeypox virus (MPXV) is an enveloped, double-stranded DNA virus belonging to the genus Orthopox viruses. In recent years, the virus has spread to countries where it was previously unknown, turning it into a worldwide emergency for public health. This study employs a structural-based drug desig...
Autores principales: | Imran, Mohd, Abida, Alotaibi, Nawaf M., Thabet, Hamdy Khamees, Alruwaili, Jamal Alhameedi, Eltaib, Lina, Alshehri, Ahmed, Alsaiari, Ahad Amer, Kamal, Mehnaz, Alshammari, Abdulmajeed Mohammed Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377189/ https://www.ncbi.nlm.nih.gov/pubmed/37509664 http://dx.doi.org/10.3390/biomedicines11072025 |
Ejemplares similares
-
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
por: Imran, Mohd, et al.
Publicado: (2022) -
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
por: Almehmadi, Mazen, et al.
Publicado: (2022) -
Comparative Proteomics and Genome-Wide Druggability Analyses Prioritized Promising Therapeutic Targets against Drug-Resistant Leishmania tropica
por: Aiman, Sara, et al.
Publicado: (2023) -
Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy
por: Alshammari, Mohammed Kanan, et al.
Publicado: (2022) -
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2023)